Sumitomo Pharma Co., Ltd. (TYO:4506)

Market Cap	726.72B +200.9%
Revenue (ttm)	453.29B +13.7%
Net Income	106.87B +352.2%
EPS	268.99 +352.2%
Shares Out	448.59M
PE Ratio	6.02
Forward PE	8.06
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,881,600
Average Volume	15,352,515
Open	1,594.00
Previous Close	1,620.00
Day's Range	1,527.00 - 1,594.50
52-Week Range	744.00 - 3,288.00
Beta	n/a
RSI	37.39
Earnings Date	May 13, 2026

About Sumitomo Pharma

Sumitomo Pharma Co., Ltd. manufactures and sells pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. The company offers pharmaceutical products, such as therapeutic agents for Parkinson's disease, depression, type 2 diabetes, systemic fungal infection, hypertension, pruritus, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia. It also provides products for atypical antipsychotic, antiepileptic, carbapenem antibiotic, and gastrointestinal; and ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1897
• Employees: 3,832
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4506

Financial Performance

In fiscal year 2026, Sumitomo Pharma's revenue was 453.29 billion, an increase of 13.66% compared to the previous year's 398.83 billion. Earnings were 106.87 billion, an increase of 352.17%.